Overview

Study of Nesiritide in Diastolic Heart Failure.

Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
We hypothesize that nesiritide will have favorable effect in decreasing heart filling pressures and echocardiogram studies.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Scios, Inc.
Treatments:
Natriuretic Peptide, Brain